That prompted the condition to vary screening guidelines. It’s also impacting discussions among lawmakers that are reconsidering the condition’s potency tax, as explained before.“Which includes led to many multi-state operators and big players to essentially monopolize the marketplaces in other states and New York is seeking to do something i